Graft-to-recipient weight ratio, recipient gender, body mass index, alpha-fetoprotein level, tumor size, and microvascular invasion, in addition to sarcopenia, were significantly associated with HCC recurrence (p < 0.05, Table 2). The gene discussed is AFP; the disease is sarcopenia.